Envista (NYSE:NVST) is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments. Its integrated approach enables dental professionals to access consumables, equipment and digital workflow tools through a unified platform, helping to streamline procedures and enhance patient care. The company supports research and development initiatives aimed at advancing digital dentistry and improving clinical outcomes.
Envista was established in July 2019 following its spin-off from Danaher Corporation, bringing together decades of dental industry expertise under a dedicated corporate structure. Since its inception, Envista has expanded its geographic reach and invested in strategic partnerships to drive innovation and market penetration. The company’s leadership team, led by a chief executive officer and experienced executives in operations, marketing and research, focuses on long-term growth through product development, acquisitions and operational excellence.
